In a study on people with obesity and asthma, researchers saw “significant” improvements in the asthma scores of people who ...

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

Experts say there’s no evidence GLP-1s can be absorbed through the skin — and these patches don’t contain the FDA-approved ...

The popular weight-loss and diabetes drugs could play a significant role not only in disease prevention, but possibly in ...

The appetite-suppressing medications reduce consumption of processed and sugary foods, creating new risks and opportunities.

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor Novo Nordisk, will still be covered under plans managed by CVS Caremark.

Weight-loss drugs like semaglutide and tirzepatide may help shrink waistlines, but new research shows they fail to boost ...

New medicines have made weight loss easier than ever. But if you also want health and happiness, make these seven psychology ...

A warning has now been issued after ‘GLP-1 weight-loss patches’ were spotted online amidst the surge in Mounjaro popularity.

Stopping anti-obesity medications leads to significant weight regain, starting as early as eight weeks and stabilizing by six ...

A new study reports that mice shed about 20% of their body weight and saw their breast cancer tumors decrease after getting ...

Unless you are from another planet, you’ve heard all about the new weight loss medications taking the world by storm. These weight loss injections, GLP-1s like Wegovy, (same drug as Ozempic ...